191 related articles for article (PubMed ID: 30760187)
1. Potential Therapeutic Applications of P2 Receptor Antagonists: From Bench to Clinical Trials.
da Silva Ferreira NC; Alves LA; Soares-Bezerra RJ
Curr Drug Targets; 2019; 20(9):919-937. PubMed ID: 30760187
[TBL] [Abstract][Full Text] [Related]
2. Purinergic Receptors in Thrombosis and Inflammation.
Hechler B; Gachet C
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2307-15. PubMed ID: 26359511
[TBL] [Abstract][Full Text] [Related]
3. [Purinergic P2-receptors as potential targets of new pharmaceutical products].
Ziganshin AU
Vestn Ross Akad Med Nauk; 2011; (11):32-8. PubMed ID: 22312906
[TBL] [Abstract][Full Text] [Related]
4. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
Jacobson KA; IJzerman AP; Müller CE
Biochem Pharmacol; 2021 May; 187():114311. PubMed ID: 33130128
[TBL] [Abstract][Full Text] [Related]
5. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
6. ATPergic signalling during seizures and epilepsy.
Engel T; Alves M; Sheedy C; Henshall DC
Neuropharmacology; 2016 May; 104():140-53. PubMed ID: 26549853
[TBL] [Abstract][Full Text] [Related]
7. Involvement of purinergic signaling in cardiovascular diseases.
Ralevic V; Burnstock G
Drug News Perspect; 2003 Apr; 16(3):133-40. PubMed ID: 12819811
[TBL] [Abstract][Full Text] [Related]
8. Drug-like Antagonists of P2Y Receptors-From Lead Identification to Drug Development.
Conroy S; Kindon N; Kellam B; Stocks MJ
J Med Chem; 2016 Nov; 59(22):9981-10005. PubMed ID: 27413802
[TBL] [Abstract][Full Text] [Related]
9. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
Washburn KB; Neary JT
Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of purinergic signalling.
Burnstock G
Biochem Pharmacol; 2018 May; 151():157-165. PubMed ID: 28735873
[TBL] [Abstract][Full Text] [Related]
11. Minor contribution of ATP P2 receptors to electrically-evoked electrographic seizure activity in hippocampal slices: Evidence from purine biosensors and P2 receptor agonists and antagonists.
Lopatář J; Dale N; Frenguelli BG
Neuropharmacology; 2011; 61(1-2):25-34. PubMed ID: 21338615
[TBL] [Abstract][Full Text] [Related]
12. P2-pyrimidinergic receptors and their ligands.
Müller CE
Curr Pharm Des; 2002; 8(26):2353-69. PubMed ID: 12369950
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists.
Lambrecht G; Braun K; Damer M; Ganso M; Hildebrandt C; Ullmann H; Kassack MU; Nickel P
Curr Pharm Des; 2002; 8(26):2371-99. PubMed ID: 12369951
[TBL] [Abstract][Full Text] [Related]
14. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.
Donnelly-Roberts DL; Jarvis MF
Br J Pharmacol; 2007 Jul; 151(5):571-9. PubMed ID: 17471177
[TBL] [Abstract][Full Text] [Related]
15. Roles of P2X7 receptor in glial and neuroblastoma cells: the therapeutic potential of P2X7 receptor antagonists.
Sun SH
Mol Neurobiol; 2010 Jun; 41(2-3):351-5. PubMed ID: 20405342
[TBL] [Abstract][Full Text] [Related]
16. P2 receptors in health and disease.
Weisman GA; Yu N; Liao Z; Gonzaléz F; Erb L; Seye CI
Biotechnol Genet Eng Rev; 2006; 22():171-95. PubMed ID: 18476331
[TBL] [Abstract][Full Text] [Related]
17. Plant natural products as source of new P2 receptors ligands.
Pacheco PAF; Diogo RT; Magalhães BQ; Faria RX
Fitoterapia; 2020 Oct; 146():104709. PubMed ID: 32829014
[TBL] [Abstract][Full Text] [Related]
18. The platelet P2 receptors in arterial thrombosis.
Gachet C; Léon C; Hechler B
Blood Cells Mol Dis; 2006; 36(2):223-7. PubMed ID: 16466948
[TBL] [Abstract][Full Text] [Related]
19. Purines and pain mechanisms: recent developments.
Liu XJ; Salter MW
Curr Opin Investig Drugs; 2005 Jan; 6(1):65-75. PubMed ID: 15675605
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
Savi P; Herbert JM
Semin Thromb Hemost; 2005 Apr; 31(2):174-83. PubMed ID: 15852221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
